Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study.

Hum Vaccin Immunother · 2017 · PMC5718801 · PMID 28605294

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At the end of the Phase IB trial, most subjects showed a trend of increasing of anti-JRC IgG production (Supplementary Documents, Table S6).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.